Research shows link between socioeconomic status and cancer life expectancy

Despite significant progress in cancer treatments, the benefits are not experienced equally across different socioeconomic groups.

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update – Biotech Investments

Issuer: CureVac / Key word(s): Quarter Results 15.08.2024 / 13:06 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Financial

August 16, 2024

The FDA needs a risk evaluation and mitigation strategy for Alzheimer’s drug lecanemab

Over the past several months, my conversations with colleagues in the Alzheimer’s field have featured an unusual sentiment: optimism inflected with worry. Optimism because, after

June 16, 2023

Docs Should Counsel Patients About IUD Pain, CDC Says

As part of an update to the CDC’s practice recommendations on contraception, physicians are being encouraged to counsel patients on pain associated with intrauterine device

August 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.